LifeVest Wearable Defibrillator Reduces Total Mortality By 36 Percent At 90 Days

March 10, 2018

Responsive image

CHELMSFORD, Mass., March 10, 2018 /PRNewswire/ — ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the results from the “Vest Prevention of Early Sudden Death Trial (VEST).” The study demonstrated…

Category: Precious Metals